GRETTA LANGLEY: Open Payments
NPI 1194214148 · JACKSONVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,481 in 76 payments from 19 companies in 2025. Trend: 2023 $1,604 · 2024 $1,557 · 2025 $1,481
Food & beverage: $1,481
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $351 |
| Novo Nordisk Inc | 17 | $305 |
| Astellas Pharma US Inc | 5 | $120 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $115 |
| Axsome Therapeutics, Inc. | 3 | $87 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $59 |
| Exact Sciences Corporation | 3 | $57 |
| PFIZER INC. | 3 | $55 |
| Abbott Laboratories | 2 | $48 |
| Dexcom, Inc. | 2 | $42 |
Products named: UBRELVY, VRAYLAR, Veozah, CAPLYTA, Kerendia, Auvelity, Rybelsus, Cologuard Collection Kit.
Industry payments across FL — which companies pay providers there.
